Accessibility Menu
Eurofins Scientific Se logo

Eurofins Scientific Se

(OTC) ERFSF

Current Price$77.54
Market Cap$13.22B
Since IPO (2004)+397%
5 Year-29%
1 Year+11%
1 Month+13%

Eurofins Scientific Se Financials at a Glance

Market Cap

$13.22B

Revenue (TTM)

€14.25B

Net Income (TTM)

€881.31M

EPS (TTM)

$2.87

P/E Ratio

26.03

Dividend

$0.84

Beta (Volatility)

0.53 (Low)

Price

$77.54

Volume

1,137

Open

$80.53

Previous Close

$77.54

Daily Range

$77.54 - $80.64

52-Week Range

$64.95 - $86.20

Estimated Earnings Date

Jul 29, 2026

ERFSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eurofins Scientific Se

Industry

Life Sciences Tools and Services

Employees

65,694

CEO

Gilles G. Martin, PhD

Headquarters

Luxembourg City, 1526, LU

ERFSF Financials

Key Financial Metrics (TTM)

Gross Margin

16.38%

Operating Margin

15.62%

Net Income Margin

6.51%

Return on Equity

11.62%

Return on Capital

10.26%

Return on Assets

4.32%

Earnings Yield

3.84%

Dividend Yield

1.09%

Payout Ratio

12.23%

Stock Overview

Market Cap

$13.22B

Shares Outstanding

170.53M

Volume

1.14K

Avg. Volume

3.35K

Financials (TTM)

Gross Profit

€5.91B

Operating Income

€2.23B

EBITDA

€2.90B

Operating Cash Flow

€2.63B

Capital Expenditure

-€1.29B

Free Cash Flow

€1.35B

Cash & ST Invst.

€790.70M

Total Debt

€4.43B

Eurofins Scientific Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

€3.68B

+11.4%

Gross Profit

€384.96M

-65.3%

Gross Margin

10.45%

N/A

Market Cap

$13.22B

N/A

Market Cap/Employee

$210.91K

N/A

Employees

62,696

N/A

Net Income

€228.31M

+43.8%

EBITDA

€716.60M

+29.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

€790.70M

-35.5%

Total Debt

€4.43B

+12.9%

Accounts Receivable

€1.54B

+11.3%

Inventory

€138.95M

-0.0%

Long Term Debt

€3.71B

+11.4%

Short Term Debt

€726.70M

+20.9%

Return on Assets

4.32%

N/A

Return on Invested Capital

13.32%

N/A

Free Cash Flow

€250.81M

-26.2%

Operating Cash Flow

€789.30M

+25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FSPKFFisher & Paykel Healthcare Corporation Limited
$22.52+0.00%
CHJTFCSPC Pharmaceutical Group Limited
$0.98+0.00%
CSPCYCSPC Pharmaceutical Group Limited
$3.84+8.17%
BIOVFSwedish Orphan Biovitrum AB (publ)
$48.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About ERFSF

What is the current price of Eurofins Scientific Se?

Eurofins Scientific Se is trading at $77.54 per share.

What is the 52-week range for Eurofins Scientific Se?

Over the past 52 weeks, Eurofins Scientific Se has traded between $64.95 and $86.20.

How much debt does Eurofins Scientific Se have?

As of the most recent reporting period, Eurofins Scientific Se reported total debt of €6.38B.

How much cash does Eurofins Scientific Se have on hand?

Eurofins Scientific Se reported €929.22M in cash and cash equivalents in its most recent financial results.

What is Eurofins Scientific Se’s dividend yield?

Eurofins Scientific Se currently has a dividend yield of 1.09%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.